Business

The ongoing tug-of-war between compounding pharmacies and big pharmaceutical companies, primarily surrounding the production of copycat drugs like Eli Lilly’s Zepbound and Mounjaro, serves as a glaring illustration of the failures within the U.S. healthcare system. Despite regulatory attempts to curtail what many believe to be an exploitative practice, patients continually find themselves caught in
0 Comments
The National Basketball Association (NBA) is reportedly reviving its classic show “NBA Inside Stuff,” a move that may seem like a simple nod to nostalgia. However, this endeavor is anything but superficial. As a culture, we often risk romanticizing the past at the expense of modern innovations and trends. While nostalgia can anchor audiences, it
0 Comments
The beverage market is undergoing a seismic shift, moving away from traditional sugary sodas towards healthier alternatives, and PepsiCo’s recent decision to acquire Poppi for nearly $2 billion underscores this transformation. The prebiotic soda segment, which has emerged dramatically over the last five years, is redefining consumer preferences, representing a demographic increasingly wary of sugar-laden
0 Comments
The intersection of food safety and health has been a contentious battleground in the political landscape, especially under the shifting administrations in Washington. Recently, Secretary of Health and Human Services Robert F. Kennedy Jr. held a notable meeting with executives from major food companies, delivering a clear message: it’s high time to eliminate harmful ingredients
0 Comments